secwatch.observer — SEC 8-K summary
======================================

Issuer:     SPLASH BEVERAGE GROUP, INC. (SBEV)
CIK:        0001553788
Form:       8-K
Filed at:   2026-07-29T20:31:21+00:00
Accession:  0001731122-26-000982
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Splash Beverage expands CannEpil license to veterinary applications, targets FDA approval
--------------------------------------------------------------------------------

- Expanded exclusive global license for CannEpil to include veterinary therapeutics; royalty 10% of vet net revenue, 15% human.
- Initial focus on canine oncology and chronic pain; global veterinary pain market ~$2.6B in 2024, projected $3.8B by 2030.
- Company finalizing joint venture with established cannabinoid pharmaceutical firm to lead veterinary development program.
- CannEpil is a pharmaceutical-grade CBD/THC oral solution with EU-GMP certification and IND for human program.
- Will pursue FDA Center for Veterinary Medicine INAD and Conditional Approval pathways; no assurance of approval.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1553788/000173112226000982/0001731122-26-000982-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1553788/000173112226000982/e7811_8-k.htm
  HTML page:      https://secwatch.observer/filing/0001731122-26-000982

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer